PUBLIC COMPANY

$CATXPerspective Therapeutics, Inc.

Seattle, WA, USupdated 1mo ago

SEC EDGAR Yahoo Finance

community read0 votes

pipeline

3

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(3)

pipeline depth3 products

3Phase 2

Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Perspective Therapeutics, Inc. jobs →

News

no news has mentioned this company yet

$CATX

Data sources

SEC EDGAR

last refreshed 5m ago

Found something off?

Active trials

phase2Lead-212 PSV359 Therapy for Patients With Solid Tumorsrecruitingn=112
phase2MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanomarecruitingn=300
phase2Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumorsrecruitingn=300
phase1Targeted Imaging of Melanoma for Alpha-Particle Radiotherapycompletedn=7

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Insider activity

source: SEC Form 4

routine RSU / option mechanics (6)

Mar 2, 26grantMartinez Maria E · director50,000 sh
Mar 2, 26grantMorich Frank · director50,000 sh
Mar 2, 26grantWilliamson Robert F III · director50,000 sh
Mar 2, 26grantHENSON HEIDI · director50,000 sh
Mar 2, 26grantWoods Lori A · director50,000 sh
Mar 2, 26grantSpoor Johan M. · Chief Executive Officer735,000 sh

$CATXPerspective Therapeutics, Inc.

Pipeline(3)

📅 Upcoming

🕒 Recent(90d)

News

Active trials

comments(0)

Insider activity

Upcoming

Recent(90d)